Wex [WEX] vs Amdocs [DOX] Detailed Stock Comparison

Wex

Amdocs
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Wex wins in 7 metrics, Amdocs wins in 12 metrics, with 0 ties. Amdocs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Wex | Amdocs | Better |
---|---|---|---|
P/E Ratio (TTM) | 20.21 | 16.66 | Amdocs |
Price-to-Book Ratio | 5.60 | 2.58 | Amdocs |
Debt-to-Equity Ratio | 556.00 | 23.65 | Amdocs |
PEG Ratio | 2.88 | 1.20 | Amdocs |
EV/EBITDA | 6.67 | 9.66 | Wex |
Profit Margin (TTM) | 11.80% | 11.94% | Amdocs |
Operating Margin (TTM) | 23.77% | 17.69% | Wex |
EBITDA Margin (TTM) | 23.77% | 17.69% | Wex |
Return on Equity | 22.19% | 15.73% | Wex |
Return on Assets (TTM) | 2.94% | 7.87% | Amdocs |
Free Cash Flow (TTM) | $329.00M | $618.93M | Amdocs |
1-Year Return | -25.85% | -6.59% | Amdocs |
Price-to-Sales Ratio (TTM) | 2.11 | 1.95 | Amdocs |
Enterprise Value | $6.00B | $9.59B | Amdocs |
EV/Revenue Ratio | 2.31 | 2.06 | Amdocs |
Gross Profit Margin (TTM) | 58.64% | 37.86% | Wex |
Revenue per Share (TTM) | $68 | $41 | Wex |
Earnings per Share (Diluted) | $7.90 | $4.94 | Wex |
Beta (Stock Volatility) | 1.26 | 0.52 | Amdocs |
Wex vs Amdocs Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Wex | -0.63% | -1.27% | -8.16% | 5.93% | 31.82% | -9.54% |
Amdocs | 0.01% | 1.19% | -3.93% | -10.23% | 0.43% | -2.06% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Wex | -25.85% | 16.03% | 5.72% | 71.97% | 317.50% | 696.38% |
Amdocs | -6.59% | 4.33% | 40.98% | 40.81% | 175.50% | 212.95% |
News Based Sentiment: Wex vs Amdocs
Wex
News based Sentiment: POSITIVE
WEX demonstrated positive momentum in October through strategic partnerships, a focus on digital innovation, and favorable analyst revisions. While some insider selling occurred, the overall narrative suggests a company positioning itself for future growth in the evolving fleet and fuel management landscape.
Amdocs
News based Sentiment: MIXED
October presented a mixed bag for Amdocs, with a revenue decline offset by positive earnings, a strong focus on AI through key partnerships, and continued institutional investment. While the downgrade introduces caution, the overall narrative suggests a company actively adapting to industry changes and positioning itself for future growth, making it a significant month for investors to assess.
Performance & Financial Health Analysis: Wex vs Amdocs
Metric | WEX | DOX |
---|---|---|
Market Information | ||
Market Cap | $5.50B | $9.09B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 290,468 | 959,580 |
90 Day Avg. Volume | 334,903 | 866,193 |
Last Close | $157.40 | $82.44 |
52 Week Range | $110.45 - $217.47 | $78.61 - $95.41 |
% from 52W High | -27.62% | -13.59% |
All-Time High | $244.04 (Apr 01, 2024) | $99.75 (Jun 26, 2023) |
% from All-Time High | -35.50% | -17.35% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.02% | -0.08% |
Quarterly Earnings Growth | -0.12% | 0.10% |
Financial Health | ||
Profit Margin (TTM) | 0.12% | 0.12% |
Operating Margin (TTM) | 0.24% | 0.18% |
Return on Equity (TTM) | 0.22% | 0.16% |
Debt to Equity (MRQ) | 556.00 | 23.65 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $28.53 | $31.85 |
Cash per Share (MRQ) | $143.44 | $3.11 |
Operating Cash Flow (TTM) | $424.70M | $737.18M |
Levered Free Cash Flow (TTM) | $1.09B | $563.54M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Wex vs Amdocs
Metric | WEX | DOX |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 20.21 | 16.66 |
Forward P/E | 9.35 | 11.71 |
PEG Ratio | 2.88 | 1.20 |
Price to Sales (TTM) | 2.11 | 1.95 |
Price to Book (MRQ) | 5.60 | 2.58 |
Market Capitalization | ||
Market Capitalization | $5.50B | $9.09B |
Enterprise Value | $6.00B | $9.59B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 2.31 | 2.06 |
Enterprise to EBITDA | 6.67 | 9.66 |
Risk & Other Metrics | ||
Beta | 1.26 | 0.52 |
Book Value per Share (MRQ) | $28.53 | $31.85 |
Financial Statements Comparison: Wex vs Amdocs
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | WEX | DOX |
---|---|---|
Revenue/Sales | $636.60M | $1.14B |
Cost of Goods Sold | $270.00M | $711.15M |
Gross Profit | $366.60M | $433.29M |
Research & Development | N/A | $86.85M |
Operating Income (EBIT) | $157.30M | $202.47M |
EBITDA | $238.80M | $252.11M |
Pre-Tax Income | $100.40M | $190.77M |
Income Tax | $28.90M | $35.96M |
Net Income (Profit) | $71.50M | $154.80M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | WEX | DOX |
---|---|---|
Cash & Equivalents | $610.30M | $247.39M |
Total Current Assets | $9.17B | $1.56B |
Total Current Liabilities | $8.76B | $1.34B |
Long-Term Debt | $4.10B | $748.93M |
Total Shareholders Equity | $810.40M | $3.50B |
Retained Earnings | $2.14B | N/A |
Property, Plant & Equipment | N/A | $874.85M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | WEX | DOX |
---|---|---|
Operating Cash Flow | $163.80M | $195.07M |
Capital Expenditures | $-32.60M | $-15.96M |
Free Cash Flow | $-528.70M | $156.49M |
Debt Repayment | $-5.64B | N/A |
Common Stock Repurchase | $-790.00M | $-135.24M |
Short Interest & Institutional Ownership Analysis
Metric | WEX | DOX |
---|---|---|
Shares Short | 1.50M | 4.41M |
Short Ratio | 4.59 | 5.21 |
Short % of Float | 0.07% | 0.05% |
Average Daily Volume (10 Day) | 290,468 | 959,580 |
Average Daily Volume (90 Day) | 334,903 | 866,193 |
Shares Outstanding | 39.00M | 112.89M |
Float Shares | 29.64M | 107.73M |
% Held by Insiders | 0.01% | 0.00% |
% Held by Institutions | 1.13% | 0.99% |
Dividend Analysis & Yield Comparison: Wex vs Amdocs
Metric | WEX | DOX |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |